Quel est le prix pour Taiwan Advance Bio-Pharmaceutical Inc. (4186)

Le prix pour Taiwan Advance Bio-Pharmaceutical Inc. (4186) est $0.2518483

Quelle est la capitalisation boursière pour Taiwan Advance Bio-Pharmaceutical Inc. (4186)

La capitalisation boursière pour Taiwan Advance Bio-Pharmaceutical Inc. (4186) est $22.67M

Taiwan Advance Bio-Pharmaceutical Inc. (4186) Prix et Capitalisation Boursière

Taiwan Advance Bio-Pharmaceutical Inc. is a biotechnology enterprise with a substantial international presence, conducting operations across numerous countries such as China, Germany, the USA, Italy, Malaysia, Vietnam, Thailand, Indonesia, Japan, Korea, and Pakistan, in addition to other global markets. Founded in 1989 and headquartered in New Taipei City, Taiwan, the company delivers a comprehensive array of products and services. Its offerings encompass diagnostic kits for ensuring food safety, alongside tailored customization services for ELISA, rapid, and chemical test kits, and expert consultation for setting up food safety laboratories. The firm also specializes in manufacturing both monoclonal and polyclonal antibody products. Furthermore, its portfolio includes rapid screening tests for illicit substances. It provides essential cell banking services for the secure preservation of both newborn and adult stem cells. The company also operates a dedicated drug testing facility, performing analyses on urine and hair samples to detect and identify drug abuse.

Prix pour 4186	L’actif B	La capitalisation boursière de B	Résultats
$58,932.38 $22.67M	NVDA	$5.304T	+23,399,852.56%
$51,838.21 $22.67M	AAPL	$4.665T	+20,583,007.26%
$46,123.84 $22.67M	GOOG	$4.151T	+18,314,037.69%
$40,095.91 $22.67M	MSFT	$3.609T	+15,920,558.23%
$31,568.35 $22.67M	AMZN	$2.841T	+12,534,567.59%

Prix pour 4186

L’actif B

La capitalisation boursière de B

Résultats

$58,932.38 $22.67M